USE OF M-CSF FOR PREVENTING OR TREATING MYELOID CYTOPENIA AND RELATED COMPLICATIONS

Research output: Intellectual Property › Patent application/Patent

Contributors

  • INSERM - Institut national de la santé et de la recherche médicale
  • French National Centre for Scientific Research (CNRS)
  • Aix-Marseille Université

Abstract

The invention relates to methods and compositions comprising a macrophage colony stimulating factor (M-CSF) polypeptide or an agonist of the M-CSF receptor for preventing or treating myeloid cytopenia and related complications (such as infections) in a patient in need thereof (such as a patient undergoing hematopoietic stem cell transplantation).

Details

The invention relates to methods and compositions comprising a macrophage colony stimulating factor (M-CSF) polypeptide or an agonist of the M-CSF receptor for preventing or treating myeloid cytopenia and related complications (such as infections) in a patient in need thereof (such as a patient undergoing hematopoietic stem cell transplantation).

Original languageEnglish
IPC (International Patent Classification)C12N 5/ 0789 A I
Patent numberUS2016045567
Country/TerritoryGermany
Priority date9 Apr 2014
Priority numberWO2014EP57191
Publication statusPublished - 18 Feb 2016
No renderer: customAssociatesEventsRenderPortal,dk.atira.pure.api.shared.model.researchoutput.Patent